Therapeutic and diagnostic applications of exosomes in colorectal cancer
View abstract on PubMed
Summary
This summary is machine-generated.Exosomes are crucial in colorectal cancer (CRC), acting as diagnostic markers, therapeutic targets, and drug delivery systems. Research highlights their role in CRC progression, resistance, and potential for early detection and novel treatments.
Area Of Science
- Oncology
- Molecular Biology
- Biotechnology
Background
- Exosomes are key mediators in colorectal cancer (CRC) pathogenesis.
- Exosomal contents, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), significantly influence CRC progression and drug resistance.
Purpose Of The Study
- To review the multifaceted roles of exosomes in colorectal cancer.
- To explore their potential as diagnostic biomarkers, therapeutic targets, and drug delivery vehicles.
Main Methods
- Literature review of exosome functions in CRC.
- Analysis of exosomal lncRNAs and miRNAs in CRC progression and drug resistance.
- Evaluation of exosome-based diagnostic and therapeutic strategies.
Main Results
- Exosomal lncRNAs and miRNAs are implicated in CRC growth, metastasis, and chemotherapy resistance.
- Distinct exosomal molecular signatures offer potential for early CRC detection and treatment monitoring.
- Mesenchymal stem cell (MSC)-derived exosomes show variable effects on tumor progression.
- Multi-omics approaches and exosome-based vaccines represent emerging frontiers.
Conclusions
- Exosomes offer significant promise for advancing colorectal cancer diagnosis, treatment, and prevention.
- Continued research into exosome mechanisms and clinical applications is warranted.
- Exosome-based strategies hold potential for personalized medicine in CRC.
Related Concept Videos
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

